As for metabolism disorders, dysregulated glucose metabolism and insulin resistance stimulate insulin secretion, increasing hepatic triglyceride synthesis, which elevates plasma triglycerides and promotes NAFLD progression (89). The gene discussed is INS; the disease is Other metabolic disease.